InspireMD, Inc.
$0.77
$0.01 (+1.70%)
$0.76Day Range$0.77
Key Statistics
Market Cap
$35.46M
Shares Outstanding
46.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Aug 22, 1997
Round Lot
100
Locale
US
Trading Data
Day Open
$0.76
Day High
$0.77
Day Low
$0.76
Volume
6.4K
VWAP
$0.77
Prev Close
$0.76
Transactions
--
Acc. Volume
--
About InspireMD, Inc.
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 3841127 employees6303 WATERFORD DISTRICT DRIVE, MIAMI, FL, 33126(888) 776-6804IPO Aug 22, 1997US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001433607
- Composite FIGI
- BBG000QDM9D4
- Share Class FIGI
- BBG001T6WG65
- Ticker Root
- NSPR
- SIC Code
- 3841
About InspireMD, Inc. (NSPR) Stock
InspireMD, Inc. (NSPR) closed the 2026-09-18 session at $0.77, up 1.70% versus the previous close (+0.01). The stock opened at $0.76 and traded between $0.76 and $0.77 during that session. Session trading volume was 6K shares. The volume-weighted average price (VWAP) is $0.77.
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
InspireMD, Inc. has a market capitalization of $35.5 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. NSPR is listed on the XNAS exchange. The company employs approximately 127 people. InspireMD, Inc. is headquartered in MIAMI, FL. The recorded listing date is 1997-08-22.
On this page you can find market NSPR stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.